Emergent BioSolutions, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29089Q1058
USD
9.13
0.03 (0.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
156.10
148.70
231.10
140.90
222.20
194.70
293.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
156.10
148.70
231.10
140.90
222.20
194.70
293.80
Raw Material Cost
88.50
102.10
102.00
83.40
105.70
134.70
133.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.00
14.70
15.20
14.70
14.70
14.80
8.30
Selling and Distribution Expenses
46.60
51.10
38.80
44.00
52.70
60.70
75.90
Other Expenses
-0.05
-0.26
-0.17
-0.17
0.05
-0.56
0.49
Total Expenditure (Excl Depreciation)
145.60
165.30
154.30
140.40
173.60
204.60
223.00
Operating Profit (PBDIT) excl Other Income
10.5
-16.599999999999998
76.8
0.5
48.6
-9.9
70.8
Other Income
5.50
5.20
-3.70
-3.70
57.50
-3.30
86.20
Operating Profit (PBDIT)
40.10
12.10
96.90
20.80
132.10
12.80
184.10
Interest
11.00
14.70
15.20
14.70
14.70
14.80
8.30
Exceptional Items
8.40
-24.60
-0.30
1.10
1.30
0.40
-6.30
Gross Profit (PBDT)
67.60
46.60
129.10
57.50
116.50
60.00
159.90
Depreciation
24.10
23.50
23.80
24.00
26.00
26.00
27.10
Profit Before Tax
13.40
-50.70
57.60
-16.80
92.70
-27.60
142.40
Tax
6.60
3.90
6.40
-4.80
24.70
3.70
27.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
6.80
-54.60
51.20
-12.00
68.00
-31.30
114.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
6.80
-54.60
51.20
-12.00
68.00
-31.30
114.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
6.80
-54.60
51.20
-12.00
68.00
-31.30
114.80
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
523.10
522.60
582.50
536.20
552.70
482.80
508.40
Earnings per share (EPS)
0.07
-1.04
0.91
-0.22
1.19
-0.58
2.06
Diluted Earnings per share
0.07
-1.04
0.91
-0.22
1.19
-0.58
2.06
Operating Profit Margin (Excl OI)
6.73%
-11.16%
33.23%
0.35%
21.87%
-5.08%
24.1%
Gross Profit Margin
24.02%
-18.29%
35.22%
5.11%
53.42%
-0.82%
57.69%
PAT Margin
4.36%
-36.72%
22.15%
-8.52%
30.6%
-16.08%
39.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 4.98% vs -35.66% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 112.45% vs -206.64% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 401.45% vs -93.14% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -25.17% vs -3.29% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Emergent BioSolutions, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
156.10
0.00
156.10
Other Operating Income
0.00
0.00
0.00
Total Operating income
156.10
0.00
156.10
Raw Material Cost
88.50
0.36
88.14
24,483.33%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
11.00
1.85
9.15
494.59%
Selling and Distribution Expenses
46.60
14.55
32.05
220.27%
Other Expenses
-0.05
1.91
-1.96
-102.62%
Total Expenditure (Excl Depreciation)
145.60
35.86
109.74
306.02%
Operating Profit (PBDIT) excl Other Income
10.50
-35.86
46.36
129.28%
Other Income
5.50
3.81
1.69
44.36%
Operating Profit (PBDIT)
40.10
-31.69
71.79
226.54%
Interest
11.00
1.85
9.15
494.59%
Exceptional Items
8.40
0.00
8.40
Gross Profit (PBDT)
67.60
-0.36
67.96
18,877.78%
Depreciation
24.10
0.36
23.74
6,594.44%
Profit Before Tax
13.40
-33.91
47.31
139.52%
Tax
6.60
-0.24
6.84
2,850.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
6.80
-33.67
40.47
120.20%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
6.80
-33.67
40.47
120.20%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6.80
-33.67
40.47
120.20%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
523.10
241.83
281.27
116.31%
Earnings per share (EPS)
0.07
-0.40
0.47
117.50%
Diluted Earnings per share
0.07
-0.40
0.47
117.50%
Operating Profit Margin (Excl OI)
6.73%
0.00%
0.00
6.73%
Gross Profit Margin
24.02%
0.00%
0.00
24.02%
PAT Margin
4.36%
0.00%
0.00
4.36%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 15.61 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 4.98% vs -35.66% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -29.75% vs -26.03% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 0.68 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 112.45% vs -206.64% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -90.00% vs 655.56% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.46 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 401.45% vs -93.14% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -53.62% vs 8.75% in Mar 2025

Quarterly - Interest
Interest 1.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -25.17% vs -3.29% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -25.17% vs -39.51% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.73%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025